Profil
Kevin L.
Cook served as the Chief Financial & Accounting Officer at Lineage Cell Therapeutics, Inc. in 2021-2022.
Prior to that, he was the Chief Financial Officer at Asterias Biotherapeutics, Inc. He also served as the Chief Operating Officer at Grade Water & Power LLC in 2020-2021.
Cook received his undergraduate degree from the University of California, Davis and his MBA from Kellogg School of Management.
Anciens postes connus de Kevin Cook
| Sociétés | Poste | Fin |
|---|---|---|
| LINEAGE CELL THERAPEUTICS, INC. | Directeur Financier/CFO | 08/07/2022 |
| Grade Water & Power LLC | Directeur des opérations | 01/06/2021 |
| ASTERIAS BIOTHERAPEUTICS INC | Directeur Financier/CFO | - |
Formation de Kevin Cook
| University of California, Davis | Undergraduate Degree |
| Kellogg School of Management | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| LINEAGE CELL THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Asterias Biotherapeutics, Inc.
 Asterias Biotherapeutics, Inc. BiotechnologyHealth Technology Asterias Biotherapeutics, Inc. is a clinical-stage biotechnology company, which focuses on developing and commercializing novel therapies in the emerging fields of cell therapy and regenerative medicine. Its product candidates include AST-OPC1, trial for spinal cord injuries; AST-VAC1, a patient specific cancer immunotherapy focused on acute myeloid leukemia; and AST-VAC2, a non-patient-specific cancer immunotherapy for non-small cell lung cancer. The company was founded on September 24, 2012 and is headquartered in Fremont, CA. | Health Technology |
| Grade Water & Power LLC |
